Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 30 2020

Full Issue

The Race To Vaccinate: UK Prepares To Start Soon

News reports are from England, Russia, China, Brazil, Japan, Korea and Argentina.

AP: UK Stocks Up On Vaccines, Hopes To Start Virus Shots In Days

Britain said Sunday it has secured 2 million more doses of a promising coronavirus vaccine as it gears up to launch within days the country’s most ambitious inoculation program in decades. ... The Department of Health said Sunday it had increased its order for a vaccine developed by U.S. firm Moderna from 5 million to 7 million doses, enough for 3.5 million people. The Moderna vaccine is expected to be referred soon to the U.K.’s Medicines and Healthcare Products Regulatory Agency, to see if it is safe and effective. Two other vaccines — one developed by Pfizer and German firm BioNTech, the other by Oxford University and AstraZeneca — are already being assessed by the regulator, the final stage before being rolled out. (Lawless, 11/29)

Bloomberg: U.K. Set To Be First To Clear Pfizer-BioNTech Covid Vaccine

The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s Covid-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as early as this week, according to a person familiar with the situation, who asked not to be identified because the process is confidential. (Hipwell, Kresge and Ross, 11/28)

Bloomberg: U.K. Moves To Get Astra Covid Vaccine Approved Before The EU

Health Secretary Matt Hancock asked the U.K. medical regulator to potentially bypass its European Union counterpart and approve the supply of AstraZeneca Plc’s coronavirus vaccine to speed its deployment. Until the end of the year, when the U.K. exits a post-Brexit transition period, vaccines there must be authorized by the European Medicines Agency. But on Friday, Hancock said he invoked a special rule allowing Britain’s Medicines and Healthcare products Regulatory Agency to authorize a temporary supply of the vaccine Astra is developing with Oxford University if the data is robust enough, after it showed positive results in trials this week. (Morales, 11/26)

In other global developments —

AP: Brazil's Bolsonaro Rejects COVID-19 Shot, Calls Masks Taboo

Brazilian President Jair Bolsonaro says he won’t take any working COVID-19 vaccine himself and calls the use of masks to limit the spread of the disease “the last taboo to fall.” Bolsonaro’s comments, broadcast on his social media channels Thursday night, alarmed health experts who said they could undermine efforts to achieve vaccination levels essential to halting the pandemic and might scare off vaccine makers negotiating with local authorities. (Savarese, 11/27)

The Washington Post: Japan, Korea Young Women Suicides Spike In Coronavirus Pandemic 

Suicide rates among young women have increased notably in Japan and South Korea, raising possible links to the prolonged coronavirus pandemic as it amplifies stress levels, worsens economic woes and aggravates feelings of loneliness and isolation. No comprehensive global studies are yet available on whether the pandemic has caused higher suicide numbers or how it may have affected different age groups and genders. (Denyer and Kashiwagi, 11/29)

Also —

The New York Times: Offices Of Diego Maradona’s Doctor Raided Over His Death 

The authorities searched the home and offices of Diego Maradona’s personal doctor on Sunday as part of an investigation into the circumstances surrounding the soccer star’s death last week. Prosecutors requested a search warrant for the doctor, Leopoldo Luque, after collecting evidence and interviewing Mr. Maradona’s relatives, according to a statement by the prosecutor’s office in San Isidro, Buenos Aires Province. The statement did not provide more details. (Politi and Kwai, 11/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF